Rylee Kercher Olm

Associate

Rylee Kercher Olm represents clients in all facets of commercial litigation. Prior to joining Keker, Van Nest & Peters, Ms. Olm served as a clerk to Judge Morgan Christen of the U.S. Court of Appeals for the Ninth Circuit in Anchorage, Alaska. She was formerly an associate in the San Francisco office of a large firm where she litigated environmental and energy matters involving CEQA, contract law, nuisance law, property issues, and Proposition 65.

Ms. Olm earned her J.D. from Stanford Law School and her M.S. in Environment and Resources from Stanford. She graduated from the University of Pittsburgh, summa cum laude, with a B.A. in Environmental Studies. 

Rylee Kercher Olm represents clients in all facets of commercial litigation. Prior to joining Keker, Van Nest & Peters, Ms. Olm served as a clerk to Judge Morgan Christen of the U.S. Court of Appeals for the Ninth Circuit in Anchorage, Alaska. She was formerly an associate in the San Francisco office of a large firm where she litigated environmental and energy matters involving CEQA, contract law, nuisance law, property issues, and Proposition 65.

Ms. Olm earned her J.D. from Stanford Law School and her M.S. in Environment and Resources from Stanford. She graduated from the University of Pittsburgh, summa cum laude, with a B.A. in Environmental Studies. 

Genentech Dispute Highlights Growing Importance of Trade Secrets for Life Sciences Companies

September 16, 2019

The issues at stake in the case illustrate the growing importance of trade secrets protection to life sciences companies and the IP professionals who serve them. Read more

Trade Secrets Case Sees Biotech Shutdown Biosimilar Production

September 09, 2019

Genentech reaches a settlement agreement with JHL Biotech, which sees the latter cease development of biosimilars to Genentech’s products. Read more

Genentech Gets Taiwanese Co. to Abandon Biosimilars

September 09, 2019

Taiwan’s JHL Biotech has agreed to stop developing copycat versions of four Genentech biologics as part of a deal to end high-stakes trade secrets litigation. Read more